搜索
艾昆纬
IQV添加自选
185.635USD
+14.355+8.38%
收盘 06/24, 16:00（美东）报价延迟15分钟
30.98B总市值
22.86市盈率 TTM
关键数据
174.850今开
187.790最高
1.86M成交量
22.86市盈率 TTM
13.06市盈率动
--股息TTM
1.12%换手率
171.280昨收
174.850最低
178.26M成交额
22.57市盈率静
4.98市净率
0.00%股息率 TTM
4.87%ROA
247.04552周最高
0.90量比
1.37B净利润
166.90M总股本
8.1215每股收益TTM
1.21Beta
22.71%ROE
136.41052周最低
7.55%振幅
25.70%毛利率
30.98B总市值
2.51回报/风险
2.28%风险率
TradingKey 艾昆纬股票评分
单位: USD 更新时间: 2026-06-24操作建议
艾昆纬当前公司基本面数据相对稳定，增长潜力很大。当前估值合理，在生物技术与医疗研究行业排名1/388位。机构持股占比非常高，近一月多位分析师给出公司评级为买入。最高目标价228.36。中期看，股价处于上升通道。近一个月，市场表现较强，技术面和基本面综合得分较高，较强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间，可以做区间波段操作。
艾昆纬评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
过冷
过热
看空
艾昆纬亮点
亮点风险
IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. It offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
行业龙头
公司营业收入处于行业前列，最新年度总收入16.31B美元
估值低估
公司最新PE估值22.86，处于3年历史低位
机构减仓
最新机构持股173.06M股，环比减少5.25%
大卫·赫罗持仓
明星投资者大卫·赫罗持仓，最新持仓市值12.56M
分析师目标
根据
25
位分析师
买入
评级
228.356
目标均价
+36.11%
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
艾昆纬简介
IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. It offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
公司代码IQV
公司艾昆纬
CEOBousbib (Ari)
网址https://ir.iqvia.com/
相关品种
热门品种
常见问题
艾昆纬(IQV)的当前股价是多少？
艾昆纬(IQV)的当前股价是 185.63。
艾昆纬的股票代码是什么？
艾昆纬的股票代码是IQV。
艾昆纬股票的52周最高点是多少？
艾昆纬股票的52周最高点是247.04。
艾昆纬股票的52周最低点是多少？
艾昆纬股票的52周最低点是136.41。
艾昆纬的市值是多少？
艾昆纬的市值是30.98B。
现在艾昆纬(IQV)的股票是买入、持有还是卖出？
根据分析师评级，艾昆纬(IQV)的总体评级为买入，目标价格为228.36。
艾昆纬(IQV)股票的每股收益（EPS TTM）是多少
艾昆纬(IQV)股票的每股收益（EPS TTM）是7.91。
